Will psoriasis come back when treated with secukinumab?

Secukinumab (Secukinumab) is mainly used for systemic treatment or the treatment of moderate to severe psoriasis that meets the characteristics of phototherapy. Psoriasis is a chronic disease that is difficult to cure clinically. Psoriasis can relapse after treatment with secukinumab. However, there are no clear clinical statistics on the recurrence rate of secukinumab. Secukinumab is a human interleukin -1L-17A antagonist. Its main component is Secukinumab . It can reduce the elevated levels of epidermal neutrophils and IL-17A caused by psoriasis and control psoriasis. The clinical use of secukinumab generally requires long-term maintenance treatment as directed by the doctor. Therefore, secukinumab can only inhibit the increase in IL-17A but cannot completely solve the problem.